{"date":"2025-08-21","count":24,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6666-2025-08-21-1915-xyhazt","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"19:15:16","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-21 19:15，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-08-21-1914-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"19:14:57","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-21 19:14，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-08-21-1811-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-08-21","time":"18:11:08","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-08-21 18:11，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-08-21-1718-i4opq9","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"17:18:30","subject":"公告更正本公司114年第二季合併財務報告附註揭露內容","clause":"第51款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-08-21 17:18，「公告更正本公司114年第二季合併財務報告附註揭露內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-21-1708-lrkgsj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"17:08:27","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-21 17:08，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-08-21-1700-18hxhhr","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"17:00:02","subject":"公告本公司受統一證券邀請舉辦線上公開法人說明會","clause":"第12款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-08-21 17:00，「公告本公司受統一證券邀請舉辦線上公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-21-1652-lrkgsj","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"16:52:05","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-21 16:52，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-08-21-1647-1afxkeg","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:47:35","subject":"本公司董事會決議通過現金增資子公司Applied BioCode, Inc.案","clause":"第20款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-08-21 16:47，「本公司董事會決議通過現金增資子公司Applied BioCode, Inc.案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-08-21-1629-yogv8o","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:29:32","subject":"公告本公司董事會決議本公司114年第二季先不予分派股利","clause":"第14款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-08-21 16:29，「公告本公司董事會決議本公司114年第二季先不予分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-08-21-1627-1tgljlp","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:27:58","subject":"公告本公司董事會通過114年第二季度合併財務報告","clause":"第31款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-08-21 16:27，「公告本公司董事會通過114年第二季度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-21-1622-1kqsn3a","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:22:36","subject":"公告本公司114年第2季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-21 16:22，「公告本公司114年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-08-21-1613-sqxsg4","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:13:05","subject":"公告本公司董事會決議通過113年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-08-21 16:13，「公告本公司董事會決議通過113年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-08-21-1611-us44za","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"16:11:28","subject":"公告本公司舉辦114年第二次線上法說會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-08-21 16:11，「公告本公司舉辦114年第二次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-08-21-1608-yclg0e","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:08:27","subject":"公告本公司因會計師事務所內部輪調更換會計師","clause":"第7款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-08-21 16:08，「公告本公司因會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-08-21-1604-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"16:04:36","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-08-21 16:04，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-08-21-1515-1nsksc0","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"15:15:33","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-08-21 15:15，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-08-21-1509-uyflip","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-08-21","time":"15:09:59","subject":"本公司董事會決議買回本公司股份","clause":"第35款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-08-21 15:09，「本公司董事會決議買回本公司股份」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-08-21-1508-1fs7s1p","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-21","time":"15:08:57","subject":"公告本公司114年第二次股東臨時會通過解除董事競業禁止之限制案","clause":"第22款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-08-21 15:08，「公告本公司114年第二次股東臨時會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-08-21-1507-1ye5yun","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-21","time":"15:07:12","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-08-21 15:07，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-08-21-1505-1oaruz7","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-21","time":"15:05:00","subject":"公告本公司114年第二次股東臨時會增選任獨立董事一席當選名單","clause":"第6款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-08-21 15:05，「公告本公司114年第二次股東臨時會增選任獨立董事一席當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-21-1502-1wxubg0","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"15:02:51","subject":"(更正第9及第10項)本公司第七次買回公司股份期間屆滿及執行狀況","clause":"第35款","fact_date":"2025-08-17","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-21 15:02，「(更正第9及第10項)本公司第七次買回公司股份期間屆滿及執行狀況」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-08-21-1433-1cza5x2","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"14:33:29","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"第53款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-08-21 14:33，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-21-1412-mb2phq","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-21","time":"14:12:00","subject":"本公司受邀參加元富證券舉辦之生技產業論壇","clause":"第12款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-21 14:12，「本公司受邀參加元富證券舉辦之生技產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-08-21-1149-1kbupvl","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-08-21","time":"11:49:51","subject":"公告修正本公司113年度股東會年報部分內容","clause":"第9款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-08-21 11:49，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}